Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1983;80(2):192-5.
doi: 10.1007/BF00427969.

Absence of central effects in man of the benzodiazepine antagonist Ro 15-1788

A Darragh, R Lambe, C O'Boyle, M Kenny, I Brick
Clinical Trial

Absence of central effects in man of the benzodiazepine antagonist Ro 15-1788

A Darragh et al. Psychopharmacology (Berl). 1983.

Abstract

The benzodiazepines are typified by a profile of side effects which includes drowsiness, ataxia and incoordination. Ro 15-1788, an imidazodiazepine derivative, exhibits marked antagonism of the behavioural and biochemical effects of the benzodiazepines in animals and man. It is devoid of any behavioural activity in animals, except at very high doses. In the present study the effects of single rising oral doses of Ro 15-1788 on cognitive, psychomotor and subjective function in man have been assessed using a battery of psychometric tests designed to identify the sedative action of the benzodiazepines. At all doses up to 600 mg, Ro 15-1788 demonstrated none of the classical behavioural effects of the benzodiazepines.

PubMed Disclaimer

References

    1. Br J Clin Pharmacol. 1982 Nov;14(5):677-82 - PubMed
    1. Science. 1980 Jan 18;207(4428):274-81 - PubMed
    1. Annu Rev Pharmacol Toxicol. 1979;19:531-45 - PubMed
    1. J Clin Psychopharmacol. 1982 Apr;2(2):102-6 - PubMed
    1. Lancet. 1981 Jul 4;2(8236):8-10 - PubMed

Publication types

LinkOut - more resources